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Abstract
Background: Understanding the many factors that influence implementation of new programs, in addition to their
success or failure, is extraordinarily complex. This qualitative study examines the implementation and adaptation
process of two linked clinical programs within Primary Care, diabetes shared medical appointments (SMAs) and a
reciprocal Peer-to-Peer (P2P) support program for patients with poorly controlled diabetes, through the lens of the
Consolidated Framework for Implementation Research (CFIR). We illustrate the role and importance of pre-
implementation interviews for guiding ongoing adaptations to improve implementation of a clinical program, achieve
optimal change, and avoid type III errors.
Methods: We conducted 28 semi-structured phone interviews between September of 2013 and May of 2016, four to
seven interviewees at each site. The interviewees were physician champions, chiefs of primary care, pharmacists,
dieticians, nurses, health psychologists, peer facilitators, and research coordinators. Modifiable barriers and facilitators to
implementation were identified and adaptations documented. Data analysis started with immersion in the data to
obtain a sense of the whole and then by cataloging principal themes per CFIR constructs. An iterative consensus-
building process was used to code. CFIR constructs were then ranked and compared by the researchers.
Results: We identified a subset of CFIR constructs that are most likely to play a role in the effectiveness of the diabetes
SMAs and P2P program based on our work with the participating sites to date. Through the identification of barriers
and facilitators, a subset of CFIR constructs arose, including evidence strength and quality, relative advantage,
adaptability, complexity, patient needs and resources, compatibility, leadership engagement, available resources,
knowledge and beliefs, and champions.
Conclusions: We described our method for identification of contextual factors that influenced implementation of
complex diabetes clinical programs - SMAs and P2P. The qualitative phone interviews aided implementation through the
identification of modifiable barriers or conversely, actionable findings. Implementation projects, and certainly clinical
programs, do not have unlimited resources and these interviews allowed us to determine which facets to target and act
on for each site. As the study progresses, these findings will be compared and correlated to outcome measures. This
comprehensive adaptation data collection will also facilitate and enhance understanding of the future success or lack of
success of implementation and inform potential for translation and public health impact. The approach of using the CFIR
to guide us to actionable findings and help us better understand barriers and facilitators has broad applicability and can
be used by other projects to guide, adapt, and improve implementation of research into practice.
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Background
Understanding the many factors that influence implemen-
tation of new programs, in addition to their success or
failure, is extraordinarily complex. Formative evaluation,
defined as a rigorous assessment process designed to iden-
tify potential and actual influences on the progress and ef-
fectiveness of implementation efforts, is an essential
means to systematically approach this complexity [1].
Many implementation studies rely exclusively on sum-
mative data– or data outputs, products, and outcomes—
to determine program success or failure. While summa-
tive data is useful, it is not adequate to understand critic-
ally important implementation processes [1, 2]. When
used in isolation, summative data often leads to the term
“implementation black box” [3]: there is no way to
understand the specific reasons the intervention suc-
ceeded or failed, how it was actually implemented, and
how local contextual factors affected implementation.
This is where formative evaluation comes in, to fill in
these gaps and to systematically examine key features of
the local implementation setting, detect and monitor un-
anticipated events and adjust if necessary in real-time,
optimize implementation to improve potential for suc-
cess, and avoid type III errors—the failure to detect
differences between the original intervention plan and
the ultimate manner of implementation that lead to
failure to achieve outcomes [1, 4]. This understanding is
essential for efforts to sustain, scale up, and disseminate
any new program–otherwise there is potential for failure
to account for specific contextual issues in program
implementation.
Adaptations have been found to be necessary for sus-
tainable implementation [5] and are considered part of
the traditional translation pipeline (adaptations as re-
quired) [6]. Progress has been made in advancing the
science of implementation, but too often the complexity
of translating research into practice is overlooked or fol-
lows an overly simplistic model [7]. In the words of im-
plementation experts Dr. Chambers and Dr. Norton,
“Rather than assuming that adaptation of a manualized
intervention is at odds with good implementation, the
field can systematically collect information on the im-
pact of adaptation to individuals, organizations, and
communities and use this information to extend the
knowledge base of implementation of evidence-based
practices as well as ongoing improvement of the
evidence-based practices themselves” [8]. Indeed other
efforts in implementation have been described where ad-
aptations are catalogued on an ongoing basis. [9] While
the static view of adaptation has been that it is bad or to
be avoided and/or eliminated, the dynamic sustainability
model believes adaptation to be “inevitable and encour-
aged.” [7] Likewise, simplified intervention implementa-
tion overlooks the complexities of translating research to
practice and relies on a set of assumptions that limits
enhancement of fit between evidence-based interven-
tions and delivery setting. [10]
Additionally, while the evidence-to-practice gap for in-
terventions is receiving attention, it tends to be under-
studied in primary care. [11] A recent study highlighted
the importance of paying attention to context, which
was noted as frequently failing to be acknowledged, de-
scribed, or taken into account during implementation in
primary care. [11]
Accordingly, to fill this gap in the literature, we sought to
illustrate the role and importance of pre-implementation
(early) interviews for guiding ongoing adaptations to im-
prove implementation of a clinical program, achieve opti-
mal change, and avoid type III errors. We gathered detailed
pre-implementation data across five health system sites,
within primary care settings, that had each committed to
institute Shared Medical Appointments (SMAs) and in
some SMA cohorts an additional offered mutual peer sup-
port program (P2P) for adult patients with poorly con-
trolled diabetes. In particular, we examined modifiable
barriers and facilitators to implementation. We then docu-
mented the adaptations that were made in real-time to at-
tempt to improve implementation. This comprehensive
data will also facilitate and enhance understanding of the
future success or lack of success of implementation of new
innovative clinical programs such as SMAs and inform po-
tential for translation and public health impact of these [2].
Methods
This qualitative study is part of a larger implementa-
tion study, “The Shared Health Appointments and
Reciprocal Enhanced Support (SHARES) study” [12].
The SHARES study is a multi-site cluster randomized
trial of five geographically diverse Veterans Affairs
(VA) health systems evaluating the effectiveness and
implementation of diabetes Shared Medical Appoint-
ments (SMAs) with and without an additional recip-
rocal Peer-to-Peer (P2P) support program, when
compared to usual care.
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SMAs bring patients with the same chronic condition
together with an interdisciplinary team of providers to
provide shared education and support. The diabetes
SMAs consist of a series of 1–2 h sessions of 8–10 pa-
tients led by a team of health professionals. At each site,
participants have a total of approximately 8 h of sessions,
and the sessions are intended to be interactive and focus
on key diabetes self-management topics (e.g., diet, medica-
tions, physical activity, self-monitoring). The P2P program
comprises periodic peer support, [13, 14] group sessions,
and telephone contact between SMA participant pairs to
promote more effective diabetes self-management and
sustain gains achieved through the SMAs after completion
of these sessions. Outcomes will be examined across three
different treatment groups: (1) SMAs; (2) SMAs plus P2P;
and 3) usual care.
We undertook a type of formative evaluation (FE), la-
beled implementation-focused evaluation, of the SMAs
and of P2P [1]. This type of FE occurs throughout im-
plementation of the project plan: before, during, and
after implementation. This manuscript focuses on the
real-time FE that took place during the early stages of
implementation and pre-implementation.
The overarching framework for the SHARES qualitative
discovery– including the interviews, formative evaluation,
implementation, and analysis– was the Consolidated
Framework for Implementation Research (CFIR) [15]. The
CFIR provides a framework of 39 constructs from across
published implementation frameworks that describe the
organizational and contextual setting and are believed to
influence implementation. We are tracking the CFIR con-
structs across the sites throughout the project and will as-
certain how they influence implementation success during
future program evaluation.
Institutional Review Board (IRB) approval was ob-
tained from the Central IRB.
Data collection and analysis
A brief phone survey was conducted with key informants
from each site to identify potential key CFIR constructs.
We then conducted 28 semi-structured phone interviews
with participants at five VA health systems, four to seven
interviewees at each site (see Table 1). Interviews were con-
ducted between September of 2013 and May of 2016 and
lasted between 22 and 56 min (mean of 34 min). Two inter-
viewers participated in all interviews; detailed notes were
taken by both, while most of the questions were asked by
the first interviewer. The interviewees were physician
champions, chiefs of primary care, pharmacists, dieticians,
nurses, health psychologists, P2P facilitators, and research
coordinators from the local sites. After each initial inter-
view, the interviewee was then asked to recommend other
informants. This type of recruitment, called snowball sam-
pling, means that rather than determining individuals to
interview ahead of time, we asked everyone that we inter-
viewed to recommend other potential participants, includ-
ing key clinical opinion leaders. Interviewees from each site
were continually recruited until the research team felt that
qualitative data discovery had reached saturation—the point
at which new data only confirmed the themes and conclu-
sions already achieved [16].
Phone interviews were qualitative and, unlike a survey,
all questions were open-ended; interviewees were encour-
aged to share their experiences in detail to enable a thor-
ough understanding of the implementation experience
from their varying perspectives. Conducting multiple in-
terviews at each site enabled us to understand how per-
spectives compared from staff in different positions.
Our interview guide included questions about the in-
terviewee’s role in the diabetes SMAs and P2P groups,
aspects of the program they would like to change, bar-
riers and facilitators with regards to implementing/
expanding the diabetes SMAs and P2P programs, what
kinds of resources or tools they would need for imple-
mentation, need for and awareness of evidence for the
P2P program in addition to SMAs, existence of a clinical
champion or local opinion leader, and types of feedback
they would like to receive as the study progressed. Al-
though CFIR-relevant questions were asked, there were
opportunities to explore non-CFIR issues in that the in-
terviewees could discuss anything related to their imple-
mentation experience, which was described by the
participants in detail. After each interview, we developed
a list of barriers, facilitators, and tasks that we needed to
accomplish or follow up on with key staff at each of the
local sites as part of the implementation process.
The initial lists of barriers and facilitators were devel-
oped from the detailed interview notes with a quick
turnaround time to implement an immediate feedback
loop to the sites because the primary consideration was
not collecting data for “research,” but rather to imple-
ment adaptations to overcome barriers and improve the
implementation process. After these barriers were
reviewed, the implementation team worked with the
local staff from each site to make adaptations as neces-
sary. Of note, some of the adaptations were driven by
local clinical staff (see Table 2 for these details). We
shared feedback with each local site continually while
the phone interviews progressed so that suggestions
could be incorporated in a timely manner. Each of these
items was addressed to the extent that it could be prior
to a mid-implementation site visit. For any barriers that
we had not been able to address before each site visit, a
detailed summary packet was written by the project
qualitative analyst (CPK) and distributed to the imple-
mentation team members attending the site visit, with
background information and a list of questions and tasks
that still needed to be addressed. In addition, conference
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calls with individual sites occurred throughout this study
period and detailed notes about important issues were
documented and included in analysis.
Subsequent data analysis started with immersion in the
data to obtain a sense of the whole and then by cataloging
principal themes that emerged according to the CFIR
framework constructs [17, 18]. This is a type of qualitative
directed-content analysis [19] (directed initially by the CFIR
constructs). Given the CFIR has 39 broad constructs related
to implementation, although we analyzed, we did not dis-
cover any strong themes outside of the organizational pa-
rameters outlined in the framework.
Two authors (CK and MV) used an iterative
consensus-building process to code; first each team mem-
ber independently coded transcripts, and then met as a
group to discuss and reconcile codes, identify emergent
themes, and resolve discrepancies through consensus.
Each of the CFIR constructs was ranked on a scale of − 2
to + 2 (Table 3) independently by CK and MV for each site
and then were discussed until consensus ranking was
reached, taking all of the qualitative data into account.
The valence of each construct reflects the impact on im-
plementation (negative or positive); the numbers provide
a reference for the impact on implementation as weak or
strong, with 2 being the strongest. [20]
Results
Key constructs or areas of focus varied across sites. Table 2
is organized by site and CFIR construct and within that
row, highlights how the findings (barrier column) informed
our actions to improve or facilitate implementation (facili-
tator column) and what actions were taken (adaptations).
Based on our work with the participating sites to date, we
identified a subset of CFIR constructs that are most likely
to play a role in the implementation and possibly
effectiveness of the diabetes SMAs and the P2P program,
including evidence strength and quality, relative advantage,
adaptability, complexity, patient needs and resources, com-
patibility, leadership engagement, available resources,
knowledge and beliefs, and champions (Table 4). Although
data from any organizational aspect mentioned by inter-
viewees, and all CFIR constructs, were coded (see Table 2),
these specific constructs formed the basis of primary quali-
tative analyses due to the depth and frequency of the con-
struct throughout the interviews and qualitative analysis. A
definition of each CFIR construct is included in Table 2.
Evidence strength and quality
Diabetes SMA
The evidence strength and quality construct constitutes
stakeholders’ perceptions of the quality and validity of
evidence supporting the belief that the innovation will
have desired outcomes. This construct was rated posi-
tively for all sites except 1002 (see Table 2), where every
interviewee mentioned that the diabetes SMAs were
seen as extra work without added value or belief that the
innovation will have the desired outcomes. 1002 nurse
summarized these thoughts: “I’ve got to tell you, it’s a
hard sell with physicians. Even now, I don’t have a
champion for the diabetes SMA. They see it as extra
work. They don’t see the added value. It troubles me a
lot that it’s so hard to get the docs involved.” After this
barrier was discovered, our facilitation team made a visit
to present evidence and met with the local primary care
team to help educate and influence the physicians.
Diabetes SMA and P2P
The remaining four sites’ interviews demonstrated local
staff belief in the positive evidence quality for both the
diabetes SMAs and P2P. A leader from site 1004 stated,
Table 1 Qualitative interviewee titles
Job title of interviewee Site 1001 Site 1002 Site 1003 Site 1004 Site 1005 n = 28
n = 6 n = 6 n = 5 n = 7 n = 4
Clinical pharmacist (PharmD) 1 1 1 3 6
Primary Care physician 1 1 1 2 5
Nurse Manager 1 1 2
Health Psychologist (PhD) 2 1 3
Research Coordinator 1 1 2
P2P group facilitator 1 1 2
Chief of Cardiology 1 1
Chief of Primary Care 1 1
Dietician 1 1 2
Associate Chief of Staff 1 1
Chief of Ambulatory Care 1 1
Nurse 2 2
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Table 2 Detailed adaptations made in real-time by site and CFIR construct
Construct Barrier Facilitator or Adaptation
INTERVENTION CHARACTERISTICS
Intervention Source
Definition: Perception of key stakeholders about
whether the innovation is externally or internally
developed.
1001: Internal
1002: External
1003: Internal
1004: External
1005: Internal
Evidence Strength & Quality
Definition: Stakeholders’ perceptions of the
quality and validity of evidence supporting the
belief that the innovation will have desired
outcomes.
1001:
• Interviewees see benefit in social support that
SMA and P2P programs would provide. This
was also shown in their trial program.
• See also, Trialability.
• See also, Knowledge and Beliefs.
1002: 1002:
• Repeated throughout all the interviews, that
the SMAs and P2P programs are seen as extra
work and staff do not see any added value –
overall negative mindset to this
implementation.
• Our team presented evidence during the site
visit and during a local primary care team
meeting to help educate and influence the
physicians.
• Diabetes SMAs have been a hard sell with
physicians; they are not on board – they do
not see an added value.
1003:
• “Buddy system” (similar to P2P) has been
effective in other settings in the facility, which
has in turn increased support for P2P program.
• HBC believes evidence behind SMAs is good
and they were already looking for
opportunities to improve their diabetic
population outcomes. Believes the SMA and
P2P will be very “fruitful and helpful.”
• Physicians involved believe they have seen
evidence that having a peer or buddy for
support will help the diabetic population.
1004:
• Leadership is on board and thinks there is
good evidence for the positive effect of being
part of a group for the SMAs and the P2P
components.
• See also, Knowledge and Beliefs.
• See also, Leadership Support.
1005:
• The ACOS for Ambulatory Care believes
strongly in the evidence for SMAs.
• SMA PCP feels there is evidence that the SMA
and P2P will engage the patients (participants);
feels they are more motivated by hearing from
peers than from a clinician- belief of local
evidence that the group portion of the SMA
and the P2P group will be beneficial.
• See also, Knowledge and Beliefs.
• See also, Leadership Support.
Relative advantage
Definition: Stakeholders’ perception of the
advantage of implementing the innovation
versus an alternative solution.
1001: 1001:
• According to some interviewees, staff were not
encouraging their patients to attend the SMAs
because they did not see an advantage of the
SMAs compared to usual care.
• We had local staff present information about
the SMA program and the value of it to the
PCPs.
Kowalski et al. BMC Family Practice  (2018) 19:109 Page 5 of 23
Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
• Our team presented evidence during the site
visit and during a local primary care team
meeting to help educate and influence the
physicians.
1002:
• “Don’t see how it could hurt” attitude.
• Physicians see the diabetes SMAs as extra
work; do not see the added value.
• See also, Evidence Strength & Quality.
1002:
• Our team presented evidence during the site
visit and during a local primary care team
meeting to help educate and influence the
physicians.
• Nursing staff seems to be on board – believe
in peer support aspect to improve diabetes
care/outcomes for Vets. Believe Veterans listen
to peers more than clinicians.
1003:
• Have had other diabetes studies at site, but
group support was not formalized, “no
mechanism for patients who have been-there-
done-that providing support to others.”
• Health psychologist and other staff saw SMAs
as an advantage to their already mandated
diabetes education classes because they had
not translated into any action.
1004:
• Staff see a need for peer mentoring program
in Veterans especially because they are
deployed in a unit and relate to their Veteran
peers.
• A physician leader thinks that there may be a
financial benefit to the SMA group and P2P
component.
• See also, Cost.
1005:
• The Associate Chief of Staff sees the advantage
of the diabetes SMAs because he thinks it will
help with access, efficiency, and help Veterans
to learn from each other.
• Currently, the ACOS says there are 5–6
separate patients meeting with the clinical
pharmacist specialist for 30 min each going
over the same information with some
tweaking for their condition.
• Some PCPs talked about how they could see
the relative advantage of doing group visits vs.
one on one patient visits.
• See also, Cost.
1005:
• Possible added work for clinicians due to
number of patients needing clinical notes
following SMAs; described as: “It is a little bit of
extra work because I have to write you know, 8
to 12 notes rather than just the four that I
would write in two hours, but it potentially helps,
but, as a doc, that[‘s] the biggest detriment I see
to it.”
• While PCP SMA lead is excited about the
prospect of group visits, there was only a 50/
50 excitement from other PCPS at this site for
expansions of SMAs. Levels of enthusiasm
varied because some PCPs simply like the idea
of group appointments and some do not.
Adaptability 1001: 1001:
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
Definition:
The degree to which an innovation can be
adapted, tailored, refined, or reinvented to meet
local needs.
• Concern from staff if the program was not
adaptable and patients may not want to work
with their assigned partner and this may cause
them to leave the study.
• We worked with the site to come up with an
adapted plan whereby a patient who does not
work well with his/her partner can be re-paired
or put into a group of 3. We also worked with
the nurses and PCPs for their recommendation
on patients that will work well together. The
site appreciated us working with them to make
the peer pairing adaptable.
• Several staff were concerned that the locally
designed recruitment plan was too ambitious.
• Nurses originally going to take charge of SMAs,
varying levels of comfort and would need to
train too many facilitators.
• During a pre-implementation local site visit our
project staff discussed recruitment; the site did
change their recruitment strategy to be more
realistic.
1002:
• Staff here were concerned with the
standardization that they perceived was
required of their local SMAs. This site did not
feel the program was very adaptable initially.
• HBC or psychology fellow to fill role of nurses
as leaders of SMAs.
1002:
• We were able to work with the local team
through meetings and calls to ensure that the
SMAs could be adapted as each site saw fit.
Each sub-site was able to come up with its
own SMA plan.
1004:
• Site has tailored current SMA visits according
to Veteran feedback so they can get what they
want out of sessions.
Trialability
Definition: The ability to test the innovation on
a small scale in the organization, and to be able
to reverse course (undo implementation) if
warranted.
1001:
• Pilot SMA was conducted before our clinical
program began. Local staff involved decided it
was too difficult for patients to absorb all the
information in a one-day SMA. Also, because
they were making meta-adjustments/medica-
tion changes, they felt the sessions needed to
be longitudinal to titrate. “We feel we can’t fix
all of that in just one visit.”
1002:
• Piloted SMAs locally prior to implementation.
1005:
• Piloted SMAs locally prior to implementation.
Complexity = 4
Definition: Perceived difficulty of the innovation,
reflected by duration, scope, radicalness,
disruptiveness, centrality, and intricacy and
number of steps required to implement.
1002:
• Staff are “busy and stretched thin;” it is difficult
to do anything additional.
• Contrary to all our other sites we were told
that the amount of training for the peer
facilitator needed to be minimal. They had
trouble finding a P2P facilitator because of
their perception of the work required.
• Originally staff felt this project was only
supposed to be adding on the P2P
component. “Yet, somehow it has ended up to
be a lot more work for the SMA people.” Staff
feel they had to make multiple changes to the
SMAs that they were not anticipating.
• Staff expressed annoyance about the work
involved and administrative tasks: “very
frustrating,” “just more stress.” The timeline
getting pushed back “just became unnerving.”
They did not anticipate that this project
“would be so much work.”
1003:
• Staff told us their largest barrier is always
funding and finding time in staff schedules to
devote to this project.
1004:
• Very busy staff and many competing initiatives;
not only diabetes, but overall information
overload.
1001:
• Interestingly, this is the only site where we did
not hear about staff being overly busy,
stretched thin.
1002, 1003, 1004, 1005:
• Facilitation team worked with the sites
through team meetings and phone meetings
to streamline documentation, shared diabetes
SMA clinical note templates across the sites,
worked to better integrate into existing
workflow with input from staff.
Kowalski et al. BMC Family Practice  (2018) 19:109 Page 7 of 23
Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
1005:
• Although the ACOS is very supportive of the
SMAs he did say that it cannot add extra work
to his employees.
• Clinical pharmacist notes are a large barrier.
Generally, clinical pharmacist notes are very
comprehensive and they are the SMA
documenters for this site. ACOS is concerned
about the amount of time the documentation
of the diabetes SMAs will take for the clinical
pharmacists. He wants someone to make sure
that we build thoughtful templates that
capture what is taking place, but for the most
part are standard curriculum.
Design Quality and Packaging
Definition: Perceived excellence in how the
innovation is bundled, presented, and
assembled.
All sites:
We added this because of the comments from
all sites that clinical staff was not always aware
of what was happening and what the
intervention actually was –many of the staff did
not understand what P2P was and we spent a
good portion of the interviews explaining P2P.
This was not really the intention of the
interviews going in, but we spent a lot of time
on clarifications and answering questions.
Cost
Definition: Costs of the innovation and costs
associated with implementing the innovation
including investment, supply, and opportunity
costs.
1002:
• Nursing leadership has suggested cost, in
terms of staff time for the P2P facilitators, as a
barrier to implementation of this program.
1004:
• A physician leader thinks that there may be a
financial benefit to the SMA group and P2P
component.
1005:
• The ACOS feel that SMAs should improve
efficiency of care and access.
Outer setting
Patient Needs & Resources
Definition: The extent to which the needs of
those served by the organization (e.g., patients),
as well as barriers and facilitators to meet those
needs, are accurately known and prioritized by
the organization.
1001:
• Patients have pre-paid phones, run out of mi-
nutes and are not able to make calls at the
end of the month.
• Patients are “guarded” and may not want to
share phone numbers with their peer.
• Clinicians stated top barrier would be
“convincing the patients to show up.”
• Patients not motivated in general to come to
appointments or sessions unless compensated
financially.
• Lack of patient motivation or follow-though.
• Low patient attendance to SMAs and P2P
drop-ins.
• Concern that copay could contribute to poor
attendance.
• Concern about early morning start – some
Veterans come in without eating before, which
leads to very low blood sugars.
• Delays to the start of the diabetes SMAs;
knowing when the patients arrive and where
to take vitals (time).
• Plan for post-SMA continuation of care.
1002:
• Difficulties with patient recruitment for SMAs;
believe they will experience the same problem
for the P2P groups. Lack of motivation among
patients to attend.
• Local patients are elderly and very private. May
not want to work with a peer; concern about
potential mis-matches alienating patients from
participating.
1001:
• The local RA facilitated patient attendance
through reminder calls and letters.
• We worked with the local nurses to determine
how to ensure staff are better aware of when
the patients arrive for SMAs to ensure a timely
start.
• Moved SMA start time to early in morning to
resolve parking issue and in hopes to increase
attendance.
• Studied barriers to attendance – poor
attendance correlated with adherence issues.
• Adapted so that the SMA is no longer one full
day. This was done to allow time for
medication adjustments, which could not be
done when the SMA as only 1 day.
• We consulted with staff from the site to take
into account their perspective on matching
peers together and who would work best
together allowing for adaptability and patient
re-pairing.
• We also worked with site to ensure whenever
possible that these facilitators would be
sustainable across time when the research
team would no longer be involved
(transference of some of these tasks in time to
local clinical and administrative staff).
• Worked to guarantee eligibility for travel pay
for SMAs.
1002:
• The local RA facilitated patient attendance
through reminder calls and letters.
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
• Concern about distance – many Veterans live
far from this VA.
• Concern Veterans may not want to stay after
the SMA for P2P.
1003:
• Patient attendance/compliance is
low—particularly among patients with A1cs
over 9.
Elderly population with less financial means;
many do not have phones or access to the
internet.
• Patients resistant to change.
• Concerns from multiple staff about “passive
patient population” through experience with
SMAs patients tend to be passive and expect
you to do something rather than making a
change for themselves.
• Some patients prefer not coming to clinic
unless they will receive travel pay.
• Concerns about attendance due to ongoing
construction.
1004:
• All interviewees mentioned that it is difficult to
get buy-in from patients to participate in
groups.
• In their experience with recruiting for the
diabetes SMAs you need to recruit 3 patients
for every 1 who attends.
• VA does not reimburse patients for travel to
research visits. Sometimes patients would like
to join the groups but cannot afford to travel
without compensation.
• Many patients at this site use disposable
phones so their phone numbers frequently
change. Nurses have this experience when
they try to call patients for reminders.
• Some Veterans work and take classes, making
timing/attendance difficult.
• Presentations were given at staff meetings to
increase patient attendance/ referrals.
• We worked with staff from the site to consider
their perspective on matching peers together
and which would work best together (taking
into account disease state, gender, age).
• Worked to guarantee eligibility for travel pay
for SMAs.
• As above worked with site to ensure
sustainability of facilitators.
1003:
• The local RA facilitated patient attendance
through reminder calls and letters.
• Word of mouth support from Veterans who
have participated in the diabetes SMAs to
other Veterans has helped. This has been
mostly serendipitous rather than organized. We
discussed this with the local site PI and she
presented information on P2P to a Veteran-run
wellness group to help with the word-of-
mouth support.
• We instituted a way to distribute reminders for
the P2P groups.
• We worked to make sure the initial group
script is very dynamic.
• Worked to guarantee eligibility for travel pay
for SMAs.
• SMAs have been modified to better fit patient
needs (number of sessions, etc.)
• Veterans appreciate having an interdisciplinary
team to guide them.
• Social support will increase patient
accountability/attendance.
• As above worked with site to ensure
sustainability of facilitators.
1004:
• The local RA facilitated patient attendance
through reminder calls and letters.
• One facilitator staff has noticed is having 2
health psychologists participate in the SMAs to
make sure that patients’ needs and wants are
addressed in the class and moving the
sessions to more of a conversation rather than
a didactic session—has already been
successful.
• Vets will benefit from added social support
and “hearing from ‘equals’ rather than
somebody else.”
• Worked to guarantee eligibility for travel pay
for SMAs.
• As above worked with site to ensure
sustainability of facilitators.
1005:
• The importance of goal setting, as a patient
need, was discussed in regards to prior SMAs
and how that was needed to improve
outcomes – being held accountable helps to
improve patient outcomes.
• The local RA facilitated patient attendance
through reminder calls and letters.
• Social support is seen as a patient need and
the SMA and P2P groups will fill a gap in
patient needs.
• PCPs here view the well-controlled patients at-
tending the SMAs as a facilitator.
• Worked to guarantee eligibility for travel pay
for SMAs.
INNER SETTING
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
Structural Characteristics
Definition: The social architecture, age, maturity,
and size of an organization.
1005:
• There is a new patient education room with
the exam room attached. This site was getting
ready to ramp up the SMA model. “We are well
situated to make this work.”
Networks /Communications
Definition: The nature and quality of webs of
social networks, and the nature and quality of
formal and informal communications within an
organization.
1002:
• Concern that there would be a
communication gap between the SMA
coordinator and the P2P facilitators.
• Very large project and having 3 local sites
makes it even more complicated because each
site has some differing challenges.
• Communication between main study site and
1002 cited as problematic.
• Staff can be difficult to reach and get in
contact with.
• Concern word still needs to be spread about
project.
• The overall project site staff has ongoing
difficulties in communicating with this site.
1001:
• Nurse that managed previous SMAs has well
established relationships with key stakeholders.
• PharmD & health psychology fellow offered
and gave more information to physicians at
staff meetings.
• Keeping project on MDs minds will help with
referrals to program, so staff ensure this was
done.
• Champion is also chief – runs primary care
meetings and encourages support from
physicians.
1002:
• We worked with this site and held team
conference calls and developed a plan to
address communication.
• A staff member who knows the patient panels
well is working to communicate with and
enlist her providers.
Culture
Definition: Norms, values, and basic assumptions
of a given organization.
1001:
• Multiple staff describe this site as a culture of
Veterans not wanting to participate in group
settings.
• Veterans here are very “guarded” and have
culture of not being very motivated to make
their own changes, do not bring back
homework, do not bring in things asked to
bring.
1002:
• Culturally have great difficulty getting staff to
commit a few hours a week to any type of
project, even though this site has more
financial resources than others. The site is still
very cautious to commit staff; they will not
commit to having a pharmacist attend the
SMAs unlike all other sites. There is also a
reluctance to write down responsibilities
because of a fear they will become an
expectation.
Tension for change
Definition: The degree to which stakeholders
perceive the current situation as intolerable or
needing change.
1003:
• Diabetes education classes have been
mandated, but have not “translated into
action.”
1001:
• This site has a lack of group appointments,
interviewees see need for program that will
provide extra social support.
1003:
• SMAs seen as potential solution to lack of
action/improvement in diabetes management.
• Staff see need for innovation at their facility.
1004:
• “Benefit to hearing from ‘equals’ rather than
somebody else – someone lateral as opposed
to top down…”
• Always looking for new programs to help their
“frequent flyers.”
Compatibility
Definition: The degree of tangible fit between
meaning and values attached to the innovation
by involved individuals, how those align with
individuals’ own norms, values, and perceived
risks and needs, and how the innovation fits
with existing workflows and systems.
1002:
• Had mixed drop-in sessions which they now
cannot do with diabetes SMAs.
1004:
• According to the chief of primary care, it is
very important that this process fit into the
existing workflow for implementation to
succeed.
1001:
• Local staff have confidence that research
implementation will be smooth at facility
because it will fit within existing programs.
• This innovation is considered by staff to be
good compliment to what is already going on
in patient care.
• Not a lot of diabetes programming, fits need.
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
• It is very important that we foster buy-in from
frontline providers and they need to see this
[P2P] as integrated and not imposed or there
will be pushback. We need to coordinate our
work into the suite of already existing
programs.
1002:
• SMAs were already in place at this site and P2P
perceived as easy to add on.
1003:
• Intervention fits within existing structure, some
minor changes able to be made with
information provided by innovation staff.
1004:
• Chief of primary care presented information
about P2P at a monthly staff meeting.
• We spoke with several front-line staff about
how to best integrate this with their already
existing work.
• The Director of primary care sent emails about
the project. Coming from him will help elevate
the status of the project.
• The Director of primary care will present
information at the bi-weekly meetings with
team leaders.
• Diabetes groups already running, innovation
will be able to fit within context of ongoing
groups.
Relative Priority
Definition: Individuals’ shared perception of the
importance of the implementation within the
organization.
1002:
• Intervention not on leadership radar –
voluntary, so can be first of things to go.
1004:
• The top barrier was stated to be infringement
on their previous initiatives. During the
interviews, we determined that if the staff
already involved in diabetes management feel
their work is being challenged or re-directed
by P2P it will “put their backs up.”
• Very busy staff and many competing initiatives;
not only diabetes, but overall information
overload.They
1001:
• Leadership thinks the SMA expansion will
easily fit in because already had SMAs
ongoing.
1002:
• Nurses want program to be success – trying to
enlist more people/rally support.
1004:
• The qualitative interviews with front line nurses
and physicians helped determine how to
integrate P2P with their existing workflow and
programs. We also asked for their suggestions
for modifications to enable local success and
gain buy-in.
• Chief of primary care circulated info to those
involved in a strategic planning initiative to let
them know what will be happening and how
to incorporate it.
• To overcome sense of infringement the chief
of primary care suggested 3 people as
potential champions and said it was very
important for us to get them on board: 1) a
diabetes management nurse, who is the
“epicenter of things” and the “clearing point”
for diabetes management, 2) the acting chief
of pharmacy, who oversees the clinical
pharmacists in primary care, and3) a highly-
engaged dietician. We interviewed all three to
get their perspective and pull them into the
study.
• We sent the Chief of primary care a summary
to circulate to those involved in the strategic
planning initiative so all can be on same page,
let them know what’s coming and how to
incorporate it. He pulled together a
distribution list.
Readiness for implementation
Definition: Tangible and immediate indicators of
organizational commitment to its decision to
implement an innovation.
1001:
• This site is ready for implementation: the plan
for when study related SMAs will begin is in
place – recruitment strategies, SMAs already
running and have been through trial and error
period.
Leadership Engagement 1002:
• Leadership engagement is lacking compared
to the other 4 sites. Physicians are not
1001:
• We were impressed with Chief of primary care
as are local staff. Helped to convince providers
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
Definition: Commitment, involvement, and
accountability of leaders and managers with the
implementation of the innovation.
engaged or supportive of SMAs and the P2P
groups. The leader who is the chief for one
site and our local PI was mentioned as not
being influential by several local staff. This
could be complicated by the fact that there
are 3 local sites.
• Also, there was a barrier discussed
confidentially by multiple staff about a high
level leader being a barrier for this project,
specifically, as well as other projects. This
person is not supportive and has blocked
nurses from being involved in this as well as
other projects. Solving this issue was beyond
the scope of our project.
to enroll patients, blocked out time for
clinicians to be at groups, guaranteed space,
and made sure the project ran smoothly
overall.
• At this site we have support from leaders
across disciplines.
• General support for SMAs from staff.
1002:
• Multiple interviewees said staff and clinicians
are aware these programs.
1003:
• Interviewees suggest leadership engagement
is present and they have leadership support for
the SMAs and P2P. This came from multiple
staff including physicians.
1004:
• Very impressive chief of primary care. Was very
thoughtful in his remarks and what will need
to be done on his behalf for this program to
succeed. Several other staff also mentioned his
as a very supportive leader who is engaged in
this study.
• Chief of primary care offered to help us to
make sure staff see P2P as a benefit, leading
from a high level, tell others why we are
implementing P2P and that this is important
work.
• Director of primary care said data feedback is
important for his staff to stand behind this and
he offered to disseminate data to the strategic
initiative quad and everyone involved in
diabetes care.
1005:
• We were very impressed with the ACOS for
Ambulatory Care. He is extremely supportive of
the diabetes SMAs and pushing them forward
and making sure PharmDs are able to
participate despite time constraints. He sees an
advantage to having the SMAs in terms of
efficiency.
• See also, Relative Advantage and Knowledge
and Beliefs.
Available resources
Definition: The level of resources organizational
dedicated for implementation and on-going op-
erations including physical space and time.
1001:
• Space constraints for group visits.
• Rooms have been scheduled for SMAs, but
when patients arrive that space is occupied.
• Patient parking is often not available.
• Psychologist who was the P2P facilitator and
SMA facilitator was not renewed and now they
must find someone new and re-train.
• Not all resources are available for getting
patients checked in and vitals taken prior to
SMAs. For example, need their own scale.
1002:
• Space is so limited that groups here are
scheduled based on room availability rather
than staff availability.
• Facility covers a large geographic area; some
Veterans live 200 miles away from their facility.
• Cost concerns have meant that they use
volunteers for the P2P facilitator position. This
caused concern that they may not be here at
the right time or not have the right skills to
serve as the P2P facilitator. Indeed there was
P2P facilitator turnover and re-training
required.
All sites:
• Worked to find a guaranteed room (applies to
all except 1005).
• Scheduled out all rooms for SMAs and P2P
open group sessions in advance.
• P2P phone access to peers is available and
always a viable option for all.
• We did write scripts for the P2P facilitators to
ease their workload and make it easier to
understand their role. We also hosted bi-
monthly training and question and answer
sessions for them to talk to the facilitators as
well as all other site P2P facilitators.
1003:
• Made sure the classroom was reserved early
for next couple of years for P2P.
• Likely patient parking/construction problems
will be resolved by time funding comes
through.
1004:
• We worked with the local staff to ensure that
the P2P process will fit into the existing
workflow. Additionally, P2P was presented at a
monthly staff meeting by study staff.
• Director of primary care offered to help us to
make sure staff see this as a benefit, leading
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
• The amount of training for the peer facilitator
really needs to be minimal. We did not hear
this from the other sites.
• Staff are “busy and stretched thin;” it is difficult
to do anything additional.
1003:
• Patient parking is lacking and there are
construction projects ongoing.
• Group meeting space is constrained (SMAs
and P2P drop-in).
• Staff told us their largest barrier is always
funding and finding time in staff schedules to
devote to this project.
1004:
• Time demands on staff are a major issue. We
were told that if a lot of time would be
required for patient recruitment and screening
that implementation would be very difficult.
• Busy staff, competing initiatives; overall
information overload.
• Space constraints for group meetings.
• Concern there will not be enough resources to
continue program after study period ends
(SUSTAINABILITY).
• Parking can be issue.
1005:
• There is a big issue with lack of resources at
this site. This was seen in terms of clinical
pharmacist leaving and they were not able to
replace her and the resulting lack of time for
the remaining pharmDs. This may be related
to the insistence that the SMAs be kept team
specific. This issue came up at local team
meetings with pharmacists and dieticians.
• From the ACOS, “We are short-staffed right now
and we are unable to hire people.”
from a high level, tell others why we’re doing
P2P, ‘this is important work.’
• We will send ongoing data to the director of
primary care and he will disseminate to the
strategic initiative quad and everyone involved
in diabetes care.
• RA will help to relieve time demands of staff
for implementing initiative
1005:
• The ACOS is very on board (see also
Leadership) and did help to overcome some of
these barriers, such as securing time from the
PharmDs despite their initial statements that
they did not have enough time. However, see
his caveat at left.
Access to knowledge &information
Definition: Ease of access to digestible
information and knowledge about the
innovation and how to incorporate it into work
tasks.
1001:
• Chief of Primary Care aware of study.
1002:
• Extended project delays (over a year) and the
roll-out keeps getting pushed back with a lot
of time to not know what is happening has
made staff uncomfortable. Other key stake-
holders may not be aware of project because
of these delays – leadership has not pushed it
due to delays.
• Lack of awareness of project
1001:
• PharmDs speak at primary care meetings to
educate MDs about SMA groups.
• In general, most staff aware of the way study
will be conducted.
1004:
• P2P facilitator engaged and knowledgeable of
her role.
CHARACTERISTICS OF INDIVIDUALS
Knowledge & Beliefs about P2P and SMA
Definition: Individuals’ attitudes toward and
value placed on the innovation, as well as
familiarity with facts, truths, and principles
related to the innovation.
1001:
• Staff mentioned that they are curious to see if
this P2P has an added benefit to the SMAs.
Kind of a wait and see how it goes approach
more than already believing in the evidence.
• Unclear how much clinicians know about P2P
aspect of program.
• Some confusion over how patients will be
communicating.
• Some concern about patients sharing incorrect
medical information.
1002:
• Some staff were worried about the P2P group
and its purpose. They thought the patients
would be giving incorrect clinical advice to
each other.
• Some staff generally confused about the way
implementation/P2P would work.
1004:
1001:
• Champion (also chief) understands program
well and can use his knowledge to gain more
support from clinicians.
• HBC PhD Psychologist sees a potential benefit
to the P2P program in addition to the already
ongoing SMAs.
• Conference call to discuss concerns about P2P
groups—the intention and the instructions
that the P2P patients will be given; patients
will be educated and should not be
exchanging clinical advice—this will be
covered in the do’s and don’ts’ s card and in
the patient orientation.
1002:
• We held a conference call with this site to go
into detail about the P2P groups—the
intention and the instructions that the P2P
patients will be given; patients will be
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
• Some staff questioned aspects of the P2P
study evaluation such as the patients recalling
and self-reporting the number of times they
had spoken with their peer partner (for those
not using the telephone system). They do not
think patients will be able to accurately recall.
1005:
• Concern was common at this site that the
patient may give each other incorrect clinical
information when paired up in peer-to-peer.
• The dietician discussed a negative belief about
the interaction of peers and how one could be
over-bearing and change the tone.
• PCP interviewee talked about his beliefs that it
may be possible that the pairing might not be
well thought out and patients may clash or
disagree.
educated and should not be exchanging
clinical advice—this will be covered in the do’s
and don’ts’ s card and in the patient
orientation. Team calls also clarified this.
1003:
• Much more positive about the evidence
behind P2P than the other sites. Absolutely see
a need for the P2P program. Believe based on
work with other Veteran groups that it will be
very fruitful. Believe having a peer will help
with attendance and motivate Veterans to
attend. A previous local veteran-paired smok-
ing group has been successful.
1005:
• The ACOS is very supportive of SMAs. When
introduced to PACT in 2009/2010, was
introduced to concepts of SMAs – got
education on SMAs and started reading about
them and thought, “Hey this is a fantastic way
to actually create some efficiency in the way we
provide care.” He is a practicing PCP and has
numerous diabetic patients—he has been
using the clinical pharmacists and nursing staff
to help manage his diabetes patients for years.
• Leadership says that clinicians recognize that
this will have a good impact on patients, they
understand impacts on efficiency, and they
understand the concepts of peer support.
• Dieticians believe P2P will work because
patients really enjoy having someone check up
on them.
Self-efficacy
Definition: Individual belief in their own
capabilities to execute courses of action to
achieve implementation goals.
1005:
• Physician talking about engaging other
providers: “Some Primary Care providers are
better than others, and I think it’s all going to
have to do with their personality basically. I think
some docs would be very well-suited for this
where they’re not preaching at them and uh,
and is okay with, like I’m kind of okay with it go-
ing off-topic every now and then but I’ll steer it
back, uh, but I don’t have to be the center of at-
tention, do you know what I mean? I don’t
know, so it’s more of a Socratic method.”
1002:
• “Champion” confident he can organize the
logistics for the startup of project.
1003:
• P2P facilitator confident in ability to help
Veterans make changes and reach goals.
PROCESS
Planning
Definition: The degree to which a scheme or
method of behavior and tasks for implementing
an innovation are developed in advance, and
the quality of those schemes or methods.
1002:
• Staff unclear of roles in SMAs – not yet
defined.
• Lack of schedule for SMAs.
1001:
• Curriculum for SMAs tested and set prior to
implementation.
• Roles of clinicians in SMAs well defined prior
to implementation (had nurse following up
with patients for lab work, appointments,
health psychologist working on goals with
Vets, etc.)
• Educational materials are prepared for patient
use.
• Nurse involved in SMAs willing to help/seek
help in pairing Vets for P2P – can have group
of three if pairing doesn’t work well.
• Recruitment strategies thought out in terms of
available patient pools.
1002:
• Did SMA trial period prior to implementation.
• Ready for implementation due to planning –
gotten buy in at sub-site A, have organized RA.
1003:
• Self-initiated local planning. The Site PI thought
about ways to get buy-in from providers and
planned for ways to spread the word to
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Table 2 Detailed adaptations made in real-time by site and CFIR construct (Continued)
Construct Barrier Facilitator or Adaptation
patients by presenting information at other
groups.
• P2P facilitator in place and has been attending
SMAs to plan/learn more.
1004:
• A lot of local planning was done. The Chief of
primary care was very involved in making sure
this was presented to involved staff multiple
times and that buy-in from providers was
obtained.
1005:
• MD SMA group 2, talks about how the month
interval is a good plan to follow because of
the timing for when changes in behavior
occur. See also knowledge and beliefs.
Opinion Leaders
Definition: Individuals in an organization that
have formal or informal influence on the
attitudes and beliefs of their colleagues with
respect to implementing the innovation.
1002:
• The opinion leader for primary care was
named by several staff; however, he has not
been formally pulled into our project – we
tried, but have not been able to yet. The
named opinion leader/champion does not
have the necessary influence, i.e. is not really
an opinion leader.
1004:
• PI and the chief of primary care seem to be
opinion leaders backing this project—however,
as pointed out in champions, the PI has not
been able to influence 1 of the 2 SMAs groups
to be supportive of this project.
1001:
• The Director of primary care was named as an
opinion leader; he also happens to be the
champion, and a good supporter of this
project.
1003:
• Health Behavior psychologist is more of
champion, but is also somewhat of an opinion
leader for the primary care staff.
Formally appointed implementation leaders
Definition: Individuals from within the
organization who have been formally appointed
with responsibility for implementing an
innovation as coordinator, project manager,
team leader, or other similar role.
1001:
• Need for P2P facilitator who can engage
participants.
1002:
• The appointed physician implementation
leader has little influence over staff at 2 of the
local sites and several staff mentioned this.
Also, he seems to think that he has the
necessary influence, which compounds the
problem.
• General concern over roles in project/who will
be filling roles.
• P2P facilitator role of concern because seen as
a lot of work/time.
1001:
• RA role will be huge help for implementation
of program (dedicated person to perform
study related tasks).
1003:
• Have P2P leaders in mind prior to
implementation – is extremely engaged and
prioritizes innovation.
Champions
Definition: “Individuals who dedicate themselves
to supporting, marketing, and ‘driving through’
an [implementation]”, overcoming indifference
or resistance that the innovation may provoke
in an organization.
1002:
• No overall physician champion. The physicians
have not bought into the diabetes SMAs.
• The physicians see the diabetes SMA as extra
work. They do not see the added value.
• The physicians will not participate in the
diabetes SMAs. Whereas, the nurses want a
physician to be there for medical questions.
• The named physician champion for the SMA/
P2P project, does not have the influence that
he needs to have (wrong champion selected)
according to multiple staff.
1001:
• Great champion in the director of primary care
firm A. Helps with presentations, helps
convince providers to enroll patients, blocks
out time for providers to be at the groups,
secures space, oversees local running of the
project.
1002:
We worked with the chief of primary care to
present the study and try to gain physician buy-
in for the SMAs as well as P2P groups.
• Given the named champion is thought to not
have adequate influence, we tried to pull in
and speak with a physician who was named as
being influential.
1003:
• The health psychologist is a great champion
for this site. He has a great deal of expertise
and ideas to help with the project. He is very
communicative. He is very passionate about
this project and staff listen to him.
1004:
• The Chief of Primary Care is a good champion
for the diabetes SMAs.
Kowalski et al. BMC Family Practice  (2018) 19:109 Page 15 of 23
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Construct Barrier Facilitator or Adaptation
• Chief of PC also offered to send any emails to
staff that we need him to. He said the material
coming from him, would help. See also
construct – leadership support.
1005:
• The NP lead facilitator of most of the new
SMAs is a champion, she started the SMAs (see
also innovation sources), but she is also a
champion.
• Diabetes SMA has a nurse who was a big
champion and really helped with the success
of these groups according to the dietician and
the lead MD facilitator.
• The MD of the 2nd SMA group is a good
champion and his group was well run and had
good outcomes. See also innovation
participants about how the PCP champion
strategically used well-controlled patients in his
groups.
Key stakeholders
Definition: Individuals from within the
organization that are directly impacted by the
innovation, e.g., staff responsible for making
referrals to a new program or using a new work
process.
1002:
• Hard sell for physicians – do not see benefit,
takes too much time.
1001:
• PharmDs speak at primary care meetings to
educate MDs about SMA groups – overall
support from clinicians for SMAs.
• Champion also chief – engages key
stakeholders (clinicians).
1002:
• One interviewee cited a possible solution to
engage residents in innovation.
• One provider cited as enlisting physicians on
her panel.
1004:
• Chief of primary care will work to engage key
stakeholders.
1005:
• The ACOS for Ambulatory Care is a good
supporter and has been working to engage
key stakeholders in the SMAs.
Innovation participants
Definition: Individuals served by the
organization that participate in the innovation,
e.g., patients in a prevention program in a
hospital.
1001:
• Poor attendance at group meetings – Vets at
this site may not be comfortable in groups.
• Success dependent upon engagement of
participants.
• Concern over finding enough interested
participants.
1002:
Participants need to see added value in SMA to
get engagement.
1003:
• Site SMAs began with recruitment of those
with A1c’s over 9, attendance/engagement
was very low.
1004:
• Patient engagement low, patient drop-off high.
1001:
• Scheduling ahead and getting reminder calls
may help Vet attendance/engagement.
• Pairing aspect of P2P may increase
engagement among participants – peer
holding them accountable.
1002:
• Voluntary program – participants more likely to
be motivated/engaged.
1003:
• Include Vets with A1c’s under 9, which has
increased attendance and engagement in
program.
• Having formally appointed implementation
leaders (RA & P2P leader) to engage
innovation participants will help.
• Social support will increase engagement in
SMAs.
• Group setting/P2P will help to engage “passive
patient population.”
• Because travel is an issue, one interviewee
suggested a carpool setup.
1004:
• To increase engagement in SMAs/P2P, pair up
Veterans at first or second SMA (previous SMA
was only one visit).
• Psychologists have been asking Veterans what
they would like to get out of sessions/for
feedback to increase engagement.
• Let Veterans know they can self-refer.
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“I think [SMA and P2P] is another means for providing
guidance and motivation for patients with diabetes strug-
gling with their glucose to meet goals. I think we do a lot
of telling patients what to do, and I really think there’s a
benefit to hearing from ‘equals’ rather than somebody
else—someone lateral as opposed to top down with the
guiding and coaching.” A Primary Care Physician (PCP)
from site 1005 explained, “No matter how much I say,
‘Yeah, I know diabetes does this, diabetes does that,’ I
don’t have to deal with it and there’s one guy saying,
Table 3 CFIR construct ranking after pre-implementation phone interviews. Rating − 2 to + 2
Construct Site #1 (1001) Site #2 (1002) Site #3 (1003) Site #4 (1004) Site #5 (1005)
Intervention characteristics
Intervention Source Internal External Internal External Internal
Evidence Strength & Quality + 1 −2 + 1 + 2 + 1
Relative advantage −1 − 2 + 1 + 1 Mixed
Adaptability −1 − 1 Missing + 1 Neutral
Trialability + 1 + 1 Missing Missing Neutral
Complexity + 1 −2 Mixed −1 − 2
Design Quality and Packaging −1 − 1 − 1 −1 − 1
Cost −1 + 1 + 1
Outer setting
Patient Needs & Resources −2 −1 −2 − 1 + 1
Inner setting
Networks / Communications + 1 −2 Neutral Neutral Neutral
Culture −2 −2 Neutral Neutral Neutral
Tension for Change Mixed Neutral + 1 + 1 Neutral
Compatibility + 1 Mixed + 1 Neutral Neutral
Relative Priority + 1 −2 Neutral −1 Neutral
Leadership Engagement + 2 −2 + 2 + 2 + 1
Available Resources −1 −1 − 1 − 1 −1
Access to knowledge & info −1 −2 −1 − 1 −1
Characteristics of individuals
Knowledge & Beliefs about P2P Mixed −1 + 2 + 1 − 1
Self-efficacy Missing Neutral + 1 Neutral Neutral
Process
Planning + 2 Mixed + 1 + 1 Neutral
Opinion Leaders + 1 −1 + 1 Mixed Neutral
Formally appointed implementation leaders Neutral −1 + 1 Neutral Neutral
Champions + 2 −2 + 2 + 2 + 1
Key Stakeholders + 1 −2 Neutral + 1 + 1
Innovation Participants −1 Neutral −1 − 1 Neutral
Table 4 CFIR construct importance as ranked by local sites
All sites ranked very important in phone
survey, and subsequent interview data
confirmed this
All sites ranked very important or important in
phone survey, and subsequent interview data
confirmed this
Phone survey ranked as not very important;
however, data came out strongly during the
qualitative interviews
Complexity Adaptability Evidence Strength and Quality
Available Resources Compatibility Relative Advantage
Champions Patient Needs and Resources
Leadership Engagement
Knowledge and Beliefs about P2P
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‘Yeah, my blood sugar’s like this, I made this little change
and it dropped like, you know, dropped 20 or 30 points,’
and they believe them more.” Sites 1001 and 1003 also
mentioned that local evidence had shown that having a
peer or buddy for support, as is the case in the diabetes
SMAs and the P2P pairs and group sessions, helps pa-
tients with diabetes.
Relative advantage
Diabetes SMA
Perceptions of the relative advantage of diabetes SMA
programs were mixed across sites. Those sites that had
an overall positive ranking for stakeholder’s perception
of the advantage of these programs were 1003 and 1004.
As an example, a 1003 health psychologist stated, “We
do have also a diabetes education class… There’s a great
bit of information given. There is only a very small per-
centage of diabetes patients that have not taken that
class because it is essentially mandated. But, we’re find-
ing that for some reason this doesn’t translate into ac-
tion.” The need for and potential advantages of the peer
support program in this population was mentioned at
site 1004: “…especially in Veteran population because
they’re deployed in a unit and they come back in a unit.
So the peer support would be even more effective in the-
ory than in the general population…”.
There were also some references from clinicians about
advantages to leading group visits instead of one-on-one
patient appointments and that format provided a means
to hear more detailed information about patient behav-
iors, “I love talking to patients but I get tired of half-hour
slots, so anything that kind of breaks up my clinic, it’s a
slightly different format…and it’s a chance to kind of lis-
ten to the more of the social stories and kind of what’s go-
ing in [food] why do they eat at Coney Island every day
and their diet hasn’t changed, or why they’re not going to
change that.”
Sites 1001 and 1002 had negative ratings; staff did not
see an advantage compared to usual care or likewise be-
cause they saw the SMAs as added worked, without any
added value. For those sites with a negative ranking, we
asked local staff to present information about the value
and advantage to their local PCPs. During our site visits,
we also presented evidence to the primary care staff
from the literature, engaged them, and answered any
questions they had.
Diabetes SMA and P2P
Another noted advantage (see Cost in Table 2) was the
belief that the SMAs and P2P program will improve effi-
ciency of care and, therefore, increase patient access and
decrease cost. A physician leader from site 1004 said, “I
also think that it’s a good way to cut costs from health-
care because if a peer mentor can help the patient, he
can remind him to follow his appointments, take his
medications, exercise; it’s much simpler than a health
professional trying to do the same thing while juggling
other things. I think it helps from the clinical aspect, as
well as having a financial benefit…” A site 1005 clinical
leader said, “Let that dietician go over information with
8-12 people at one time, instead of one at a time. Those
kinds of efficiencies are really great and I think it will
help my dieticians, my clinical pharmacists, and my
psychologist a lot, and I think it will help the physicians
to manage their population of patients.”
Adaptabiliy
Diabetes SMA
Sites 1001 and 1002 had concerns initially that the SMA
program was not adaptable. They thought that the over-
seeing site would be dictating the content and manner
that each of the SMA sessions would be run. We worked
with both sites continually through phone calls and vir-
tual meetings to explain that the local team had flexibil-
ity and control over the SMA sessions and that our
fidelity assessment would help to account for any differ-
ences across sites.
Site 1004 had a positive rating for adaptability of
SMAs because they realized the importance of flexibility
and had tailored their SMA sessions to be adaptable so
Veterans could get what “they want and need out of each
session.” Staff at this site also had a good understanding
that we wanted the local clinical programs to be adapt-
able to fit local context.
P2P
Views on the potential adaptability of the peer support
component of the program were mixed. Site 1001 had
concerns that the program could not be adapted for pa-
tients who did not mesh well with their assigned peer.
We worked with that site to come up with an adapted
plan whereby a patient could be easily re-paired, even
with a patient outside their cohort if need be, or
assigned to a new group of 3 patients. We also imple-
mented a way of working with the local nurses and PCPs
to get their recommendations on patient pairs that
would work well together. Site 1001 also had some is-
sues surrounding their locally developed recruitment
plan that the clinical and research teams thought was
not feasible. During the site visit, we discussed this with
the local team and they adapted their recruitment plan
to be more realistic.
Complexity
Diabetes SMA and P2P
Interestingly, site 1001 staff had no concerns, even when
prompted, about staff being so busy that it would be
difficult to do anything additional or complex. However,
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that was the only site with a positive ranking. The other
four sites expressed concerns that if the programs were
complex, this would make the programs much more dif-
ficult to implement. An Associate Chief of Staff at 1005
said, “I am very supportive of this, but it can’t add work
to my people. It will have to be very efficient.” One spe-
cific complexity concern was in terms of the clinical
notes and documentation required for each SMA visit
and that the notes would be cumbersome for the clinical
pharmacist, who was the documenter at one site. “I just
want the pharmacist who will be involved to write very
short, patient specific changes. That is going to be VERY
important to me. If it is burdensome to them, they are
not going to be able to continue.” The facilitation team
worked with the site through team meetings and
in-person discussions with the clinical pharmacists to
streamline the documentation and share diabetes SMA
clinical note templates across the sites.
Sites 1002, 1003, 1004, and 1005 all expressed concern
with staff being busy and that it would be difficult to
add additional programs and find staff time to help fa-
cilitate the SMA and/or P2P group sessions. To impact
the complexity barriers, the facilitation team worked
with the local sites through team meetings and phone
calls to streamline documentation and shared diabetes
SMA clinical note templates across the sites. Additional
efforts were made to integrate the process within exist-
ing workflow–for example, allowing the clinician who
documented the diabetes SMA notes to be adaptable: in
some sites a clinical pharmacist, others a nurse practi-
tioner, or primary care physician. Likewise, the role of
the P2P facilitator varied.
Patient needs and resources
Diabetes SMA and P2P
All sites except 1005 perceived the new programs as fa-
cing multiple barriers within the CFIR construct of ad-
dressing patient needs and resources. This was the most
negatively ranked construct overall. There were a plethora
of barriers across the sites, including staff concerns about
patients being guarded and not wanting to pair up or ex-
change numbers, lack of motivation in patient population,
low patient attendance especially without financial com-
pensation for the P2P or SMA visits, difficulties with pa-
tient recruitment, long distance drives for patients to the
hospital, patients’ lack of financial resources, patient re-
sistance to change, and lack of patient follow-through
when asked to bring in or complete materials or goals. A
clinical pharmacist from site 1003 expressed it this way,
“There are many obstacles to bringing the patients in… [to
SMAs or P2P group sessions] Our population tends to be
older and on the financial scale of things, having more dif-
ficulty. Those factors set into place some natural barriers
to being compliant with appointments.”
A primary care physician at site 1001 stated, “Defin-
itely the top barrier will be convincing the patients to
show up. We invite an average of 10 people and we usu-
ally have between 4 and 7 who come and continue to
show up. I think patient buy-in is definitely a barrier.”
Site 1001 health psychologist, “I can say generally we
have a hard time getting patients to come to groups here.
We’re trying to hold them first thing in the morning so
that parking will be easier, but parking is a huge barrier.
Patients don’t want to come to anything that they per-
ceive as extra a lot of the time, because they find it so
challenging to actually physically get here, get parked
and get to their appointment.”
Site 1004 research coordinator, “People with diabetes
don’t feel well and getting them involved in something—it
is difficult. And some of our patients are still working, so
if we have classes during the day, that’s an obstacle. And
transportation. We’ve had that experience in the past
where they’d like to join but they can’t get here.”
To overcome these barriers the facilitation team worked
to make sure that patients would be eligible for travel pay
for attendance to the SMA clinical appointments and
helped with attendance by making additional reminder calls
and sending reminder letters. We worked with all sites to
ensure that, when possible, appointments were scheduled
at a convenient time for patients (also considering which
time of day each facility has the most parking availability).
We consulted with staff from the sites to consider their per-
spective on matching peers together and who would work
best together and again, allowing for adaptability and pa-
tient re-pairing. We also worked with sites to ensure when-
ever possible that these facilitators would be sustainable
across time when the research team would no longer be in-
volved (transference of some of these tasks in time to local
clinical and administrative staff).
Compatibility
Diabetes SMA and P2P
Perceptions of the compatibility of the SMA and P2P
programs were either mixed, neutral or positive for all
sites. Site 1001 and 1003 staff were confident that the
implementation process would be smooth because both
programs were designed in a way that they believed was
compatible and fit within their existing workflow and
programs. At site 1004, we heard from multiple staff that
it was very important for us to make sure the programs
were integrated into their suite of already existing pro-
grams or there would be push-back from staff. To do so,
we spoke with several front-line staff about how to best
integrate the programs with their existing work. The
Chief of Primary Care at this site also worked with us to
present information at their monthly staff meetings.
Other compatibility adaptations meant that we were
very flexible about the type of clinicians who could
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facilitate the SMAs—the main facilitators varied between
clinical pharmacists, nurses, dieticians, and primary care
providers; as long as multiple types of clinicians were in-
volved, the lead was adaptable to best suit their local
needs and staffing considerations. Additionally, we were
flexible about the role of the P2P facilitators; Veterans
with and without diabetes, research associates, and
volunteers.
Leadership engagement
Diabetes SMA and P2P
Leadership engagement was ranked positively at all sites
except one. Leaders were considered engaged when mul-
tiple interviewees expressed that a leader did things such
as: help with convincing providers to enroll patients,
block out time for clinicians to facilitate the SMAs and
staff to facilitate the P2P groups, guarantee space for the
SMA and P2P programs to be held, garner general sup-
port from staff, help with results/outcome feedback to
staff, lead from a high level, and express to staff why
they feel these programs are important. At site 1002
where leadership was lacking, a named leader for the
project was mentioned by local staff as not being influ-
ential. Additionally, there were some issues with general
lack of high leadership support at this site (beyond the
scope of this project).
Available resources
Diabetes SMA and P2P
The availability of resources was ranked the same nega-
tive value across all sites (− 1). Issues of concern in-
cluded space constraints for SMA and P2P group visits,
lack of patient parking, SMA and P2P facilitator staff
leaving after trained, staff generally busy and stretched
thin, competing initiatives, overall information overload,
and being short-staffed, “We are short-staffed right now
and we are unable to hire people.” Space was so limited
at site 1002 that SMA sessions had to be scheduled
based on room availability, rather than staff availability.
The facilitation team helped to find guaranteed rooms,
scheduled SMAs and P2P sessions early so rooms could
be booked well in advance, wrote scripts for staff, and had
monthly training for the P2P facilitators to ease their
workload and make it easier to understand their role.
Knowledge and beliefs
Diabetes SMA and P2P
There were concerns from several sites stemming from
beliefs that the patients in the SMAs or as part of their
pairing would share incorrect clinical information. Site
1002 health psychologist explained: “And one other bar-
rier potentially could be misinformation, people talk and
sometimes myths get out there and misconceptions and
what they hear by word of mouth which is not very
accurate information so…the group sessions, we don’t
know what’s going to be said between the Veterans and I
think it’s important to make sure proper education being
shared among them but I mean that’s going to be hard to
control, so that’s another downfall.”
Site 1005 had the most concerns about the patients
being paired and chatting in the SMAs, largely based on
their prior experience: “There’s been two people that used
to call each other and kind of hold each other account-
able, however, they were both very non-compliant and
didn’t give off the best information, so we were kind of
like, ‘Eh, that didn’t work out very well.’” This site also
had a concern about peer interaction during the SMAs,
as a dietician talked about a negative belief about the
interaction of peers and how one could be over-bearing
and change the tone. “Then there’s this other guy that
was coming to diabetes SMA and he made so many good
changes, [But] he kind of came off really hard to others.
He was losing weight, he was improving his A1C and we
first told him, ‘Can you share your story, can you try to
motivate these people?’ and it became really aggressive…
someone would say, ‘No, I haven’t started exercising,’ and
he’s like, ‘Why not?? Why can’t you do that?’ and it was
really offending patients. We actually had to talk to him
after…he was giving advice that more a provider
should’ve given and it was not supportive and we had
several patients call and complain about it.”
At site 1001, 1002, 1005, we held separate conference
calls, where we gave a detailed outline of the P2P pro-
gram, we explained that patients would receive orienta-
tion materials and instruction and be advised not to
exchange any clinical advice, and allowed staff to discuss
any of their concerns with facilitators.
“In the group [SMA] we do try to set goals each time.
We’ll go over the goals that they made last month…goal--
setting holds them accountable, we say, ‘Mr. so and so,
did you get on the treadmill like you said you were going
to last month?’ and if he hasn’t, it’s kind of like, ‘Oh, I let
my group down.’ It might motivate them to try again this
month and them kind of working off of each other and
holding each other accountable, which is nice.”
P2P
Site 1001 had what we termed a “wait and see” approach to
observe if the peer program had any benefit. When prompt-
ing interviewees on their beliefs about the peer program, we
were able to clear up some misperceptions and confusion
about how the patients would be communicating.
Site 1003 was the most confident in the benefits of the
peer program—they stated that they saw an absolute
need for the peer program based on other local work
with patient groups that were fruitful. They believed
having a peer would help with attendance and motivate
patients to attend. Furthering their confidence in the
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peer program, a previous local veteran-paired smoking
group had been successful.
There was pushback at sites 1001, 1002, and 1005
stemming from beliefs that matching peers would be dif-
ficult for multiple reasons. Site 1001 nurse, “Matching
the patients up will probably be the hard part, I mean if
one person doesn’t like their partner, I could see them
wanting to stop.”
Champions
Champions were ranked positively at all but one site
(1002). Interestingly, the champions’ organizational role
varied across sites: Director of Primary Care (3), Clinical
Health Psychologist (1), and Nurse Practitioner (1).
Positive champions were defined as those working to
push through any barriers and positively advocating for
the clinical programs to gain staff buy-in. The Chief of
Primary Care for 1004 was deemed a good champion by
staff at his site. He also said, “I see my role as making
sure that primary care, as a service, sees this [SMA and
P2P] as a benefit. Leading it from a high level rather and
being able to tell others why we’re doing this. I can say,
‘this is important work.’” Descriptions of what the cham-
pions did included: help with presentations, help con-
vince providers to enroll patients, block out time for
providers to facilitate/attend the groups, secure space,
and oversee local management of the project.
Many interviewees at site 1002 saw their site cham-
pion as non-influential. Facilitators worked with the
local site to try to gain physician buy-in for the SMAs
and P2P groups. In addition, we tried to pull in and
speak with a physician who was named as being influen-
tial by interviewees and staff we met on site visits.
Discussion
In this article, we described our method for identification
of contextual factors that influenced implementation of
complex diabetes clinical programs -SMAs and P2P. The
qualitative phone interviews aided implementation
through the identification of modifiable barriers or con-
versely, actionable findings. Implementation projects, and
certainly clinical programs, do not have unlimited re-
sources and these interviews allowed us to determine
which facets to target and act on for each site.
Likewise, our facilitation team used formative evaluation
to understand the context and organizational issues at
each of these VA health systems. Our approach used the
CFIR to guide us to actionable findings and help us better
understand barriers and facilitators, and variations of
those, across constructs and sites. Using the CFIR to do
this allowed us to improve the generalizability and effi-
ciency of our findings by highlighting factors that prior re-
search have identified as influencing implementation
(each of the published constructs). Additionally, our
project team and the local sites benefited from the use of
formative evaluation throughout the early implementation
process; we identified, in an ongoing manner, problems
that we had not anticipated but that needed to be ad-
dressed to optimize implementation.
The implementation of a new clinical program is very
complex and the field has recognized the need to utilize
theoretical bases of implementation to facilitate imple-
mentation itself and there have been more calls for re-
searchers to utilize existing frameworks to gain insights
into the mechanisms by which implementation is more
likely to succeed and to achieve common terminology.
[21] We believe our approach of using the CFIR to ac-
complish those goals has broad applicability and can be
used by other projects to guide, adapt, and improve im-
plementation of research into practice.
We have illustrated how pre- and early-implementation
FE is critically important in preparing for and gaining
early understanding of key factors that influence imple-
mentation processes, and future success or failure. This
early formative research shaped our implementation to
minimize type III failures. Our rich examples highlight
areas that were challenging as well as those that facilitated
implementation of both shared medical appointments,
and peer-to-peer programming. It is important to note
that there was no site that was universally positive or
negative across constructs, as often is assumed of “lag-
gard” or “early adopting” sites. Evidence strength and
quality was a negative issue at only one site (1002), but it
was very impactful there (see Table 3, − 2 ranking) and im-
portant for the facilitators to be aware of and to work to
overcome. As a result, our team presented evidence dur-
ing the site visit and during a local primary care team
meeting to help educate and influence the physicians. In
contrast patient needs and resources was a negatively
rated construct at 4 of the 5 sites, but at the 5th (1005)
was a positively ranked construct—illustrating that imple-
mentation scientists need to be very cautious of labeling
any construct as universally problematic.
Because of our intentional broad range of interviewees,
CFIR constructs could be mixed within a site. When this
was the case, the findings were discussed, weighed and
used to come up with one overall score as per CFIR
guidelines. The process is similar to consensus-based
coding; “Analysts apply a summary rating, taking all the
individual ratings and supporting qualitative summary
and rationale into consideration, and then discuss rat-
ings to achieve consensus” [22].
There are several limitations to this study. Constructs
were assigned only one rating per site using weighted
data from all respondents. Additionally, it is challenging
for implementation researchers to identify when modifi-
cations create an additional intervention; however, in
this case we classified these as local adaptations because
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the core underlying conceptual nature of the interven-
tions was maintained in each case. Program drift is
sometimes thought of as resulting in lower intervention
success due to lack of fidelity [7]. However, experts in
the field recognize that view is overly simplistic and
encourages an unnecessarily rigid view of fidelity; “this
designation decreased opportunities to learn from
evidence-based intervention adaptations that result in
improvements beyond what is expected” [10].
Conclusions
As the SHARES study progresses, these findings will be
compared and correlated to outcome measures. This com-
prehensive adaptation data collection will also facilitate and
enhance understanding of the future success or lack of suc-
cess of implementation and inform potential for translation
and public health impact. Crossing the bridge from re-
search to practice in primary care and family practice set-
tings is crucially important because in many ways we are
not reaping the full public health benefits of our investment
in research. [23] While the evidence-to-practice gap for in-
terventions in primary care is receiving attention, it tends
to be understudied. [11] We believe our approach of using
the CFIR to guide us to actionable findings and help us bet-
ter understand barriers and facilitators, has broad applic-
ability and can be used by other projects to guide, adapt,
and improve implementation of research into practice in
primary care and other clinical settings.
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